Compare MakeMyTrip Ltd (MMYT) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MakeMyTrip Ltd vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? MakeMyTrip Ltd trades at $44.27 (market cap $4.09B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.62 (market cap $2.27B). The key difference: MakeMyTrip Ltd is the larger of the two by market cap, and SELLAS Life Sciences Group Inc. Common Stock is trading nearer its 52-week high, MakeMyTrip Ltd nearer its low. Which is the better fit depends on your goals.
| MMYT | SLS | |
|---|---|---|
Market Cap | $4.09B | $2.27B |
Volume | 1,828,010 | 4,179,659 |
Sector | Consumer Cyclical | Health |
52-Week High | $94.43 | $15.46 |
52-Week Low | $36.30 | $1.39 |
Typical Hold Time | 12 Days | — |
Enterprise Value | $4.75B | $2.14B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MMYT trades at $44.06, up 1.5% with bearish technical signals but strong analyst support. The company reported $978M revenue and $95M net income for 2025, though earnings have been mixed with two recent misses. Valuation metrics show high P/E of 189 but solid gross margins of 73%. Technical indicators show oversold conditions with RSI at 25.31, while institutional sentiment remains positive with 72.7% buy ratings and $77 consensus target.
The stock presents a divergence between technical weakness and fundamental optimism. Upside potential exists from the 75% analyst price target premium and planned Indian listing, but risks include volatile earnings performance, rising debt-to-asset ratio projection to 79.9%, and competitive travel sector pressures. Current levels near support at $42-43 may offer entry points for long-term investors.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About MakeMyTrip Ltd
MakeMyTrip Ltd. is a leading online travel company in India, providing a comprehensive range of travel services and products, including air tickets, hotels, holiday packages, rail tickets, and bus tickets. The company operates its primary websites and mobile apps under the brands MakeMyTrip, Goibibo, and RedBus. MMYT serves as a key intermediary in India's fragmented travel market, leveraging its platform to offer convenience and competitive pricing to consumers and businesses.
Read more on MMYT →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
